114 related articles for article (PubMed ID: 8208540)
1. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
Zhang J; Chang CC; Lombardi L; Dalla-Favera R
Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
[TBL] [Abstract][Full Text] [Related]
4. The generation of nfkb2 p52: mechanism and efficiency.
Heusch M; Lin L; Geleziunas R; Greene WC
Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
[TBL] [Abstract][Full Text] [Related]
5. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
[TBL] [Abstract][Full Text] [Related]
6. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
Dobrzanski P; Ryseck RP; Bravo R
Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
[TBL] [Abstract][Full Text] [Related]
8. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway.
Kalaitzidis D; Davis RE; Rosenwald A; Staudt LM; Gilmore TD
Oncogene; 2002 Dec; 21(57):8759-68. PubMed ID: 12483529
[TBL] [Abstract][Full Text] [Related]
9. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Mol Cell Biol; 1995 Sep; 15(9):5180-7. PubMed ID: 7651435
[TBL] [Abstract][Full Text] [Related]
10. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
12. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
Migliazza A; Lombardi L; Rocchi M; Trecca D; Chang CC; Antonacci R; Fracchiolla NS; Ciana P; Maiolo AT; Neri A
Blood; 1994 Dec; 84(11):3850-60. PubMed ID: 7949142
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.
Ciana P; Neri A; Cappellini C; Cavallo F; Pomati M; Chang CC; Maiolo AT; Lombardi L
Oncogene; 1997 Apr; 14(15):1805-10. PubMed ID: 9150386
[TBL] [Abstract][Full Text] [Related]
15. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
[TBL] [Abstract][Full Text] [Related]
16. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
18. Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line.
Isogawa M; Higuchi M; Takahashi M; Oie M; Mori N; Tanaka Y; Aoyagi Y; Fujii M
Cancer Sci; 2008 Apr; 99(4):792-8. PubMed ID: 18377428
[TBL] [Abstract][Full Text] [Related]
19. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
20. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
